BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 26, 2003
View Archived Issues
Increased antitumor effects of bevacizumab plus 5-FU/leucovorin in colorectal cancer
Read More
Onercept effective and well tolerated in Crohn's disease
Read More
Kowa claims four series of cell adhesion inhibitors for allergy, asthma, etc.
Read More
New 5-HT receptor modulators and their use claimed in Pharmacia patent
Read More
Neurogen identifies compounds with affinity for GABA-A receptors
Read More
New GSK-3 inhibitors in AstraZeneca development pipeline
Read More
Chemokine CCR4 receptor modulators designed by Tularik researchers
Read More
Orion scientists prepare inhibitors of Na+/Ca2+ exchange with potential as antiarrhythmic agents
Read More
Gentris and Sankyo establish pharmacogenomics partnership
Read More
Enrollment completed in phase III PRIMO-CABG trial of pexelizumab
Read More
Medinox completes phase I study for MX-1094 for arthritis
Read More
CPMP recommends approval of Remicade for ankylosing spondylitis, label expansion
Read More
Positive opinion for Aldurazyme in E.U.
Read More
Viread recommended for approval in E.U. for use in treatment-naive HIV patients
Read More
Resiquimod development suspended following disappointing preliminary trial data
Read More
GlaxoSmithKline develops new meningitis vaccine for Africa
Read More
TaiGen and Fujisawa sign licensing and collaboration agreement
Read More
Aventis and CSL discuss potential acquisition of Aventis Behring
Read More
Fujisawa seeks European marketing clearance for candin antifungal agent
Read More
Targeting scavenger receptor BI for the treatment of infection, sepsis and inflammation
Read More
Licensing opportunity: murine MAb for detecting and quantitating CXCR4
Read More
Initial phase III AIDSVAX results do not reach primary endpoint
Read More
Retisert filing for posterior uveitis now scheduled for mid-2004
Read More
Dual inhibitor of Src and Abl kinases SKI-606 exerts potent antileukemic activity
Read More